HomeNews

News

  • Eisai and Biogen report positive results for Alzheimer’s drug BAN2401

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Titan postpones Parkinson’s implant trial program

    • July 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Neupro approved in China to treat Parkinson’s disease

    • July 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Pre-clinical data for EHP-101 in Multiple Sclerosis, presented by Emerald

    • July 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Ph 3 Efficacy data presented for Eptinezumab in Episodic and Chronic Migraine

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA Approves new Initiation drug, ARISTADA INITIO, for Schizophrenia

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE rejects Ocrevus for PPMS, citing cost concerns

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Hypertension drug shows positive Ph 3 Parkinson’s results in mice

    • July 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Biohaven to test Rimegepant as a preventive Migraine treatment as well

    • July 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Galcanezumab reduces migraine days in patients failing on Botox

    • July 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more